3 Rules Biotech Investors Need to Live By

The Life Sciences Report | |

Excellent diligence doesn't always mean you'll be saved from a nasty surprise. The nature of investing in biotech means assuming the risk that a therapeutic development program may fail.

Markets Forget About Monday with Stocks Higher for Second Consecutive Session

Michael Teague | |

Stocks on Wall Street ended significantly higher for a second consecutive day on Wednesday, as investors rejoiced in the improbable, yet very real passage of a $1.1 trillion budget deal in

Health Care's Five Best (and Worst) Performers of 2013

Joel Anderson | |

It’s been a pretty wild year for the health care sector. Public attention was captured by the relatively disastrous rollout of Obamacare’s exchanges, and the plethora of opinions that

Amarin (AMRN) Plunges Again on FDA Announcement

Joel Anderson | |

Amarin Pharmaceuticals (AMRN) took another hit Wednesday during a year that’s been a rough one for the company as a whole. Amarin was off over 14 percent in trading on Wednesday after the

US Appeals Court Clears Way for Generic Omega-3 Pills

Jacob Harper | |

Reversing an earlier US district court decision on Sept. 12, a US appeals court ruled both Teva Pharmaceutical Industries Ltd. (TEVA) and Par Pharmaceuticals could go ahead with plans to market a

Stocks Under $10: Buy Rated Biomed/Genetics Companies in the Medical Space

Richard Suttmeier | |

At we show that the Medical sector 12.6% overvalued with the Medical Biomed/Genetics 15.4% overvalued. All six stocks in today’s table have complete ValuEngine data and have

Stock Buyback Plans Lift Carnival and Agilent Shares

Andrew Klips | |

Shareholders of Carnival Corp. (CCL) and Agilent Technologies Inc. (A) got a pleasant surprise Thursday morning as each of the companies announced fresh stock repurchase plans.Miami, Florida-based

Equities Sector Coverage: Stocks Close Lower on No Progress for Fiscal Cliff

Sector Recap | |

The S&P Case/Shiller 20-City Home Price Index rose 0.3% month over month in September, the sixth consecutive monthly rise, and rose 3.0% year over year. The index is up 9.0% from its March

Equities Sector Coverage: Stocks End Higher on Jobs Numbers

Sector Recap | |

ADP reported that private sector jobs rose by 162,000 in September. Non-manufacturing ISM came in stronger than expected at 55.1 in September. The employment component fell to 51.1 from 53.8. The

Equities Sector Coverage: Rocky Global Economy Has Investors Worried

Sector Recap | |

The Conference Board reported that Leading Indicators rose 0.7% in February. Gold declined from $1656.6 the Troy ounce to $1625.0 staying below its 200-day simple moving averages at $1681.3 for


Symbol Last Price Change % Change






INTERVIEW: CEO Dr. Martin Eaton - Heads Up Checkup Host & Contributor Silvia Davi interviewing CEO of Heads Up Checkup, Dr. Martin Eaton.